{"id":"https://openalex.org/W71275700","doi":null,"title":"Pharmacokinetics and pharmacodynamics of aliskiren, an oral direct renin inhibitor.","display_name":"Pharmacokinetics and pharmacodynamics of aliskiren, an oral direct renin inhibitor.","publication_year":2008,"publication_date":"2008-09-01","ids":{"openalex":"https://openalex.org/W71275700","mag":"71275700","pmid":"https://pubmed.ncbi.nlm.nih.gov/19066408"},"language":"en","primary_location":{"id":"pmid:19066408","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19066408","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological reports : PR","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110598166","display_name":"W\u0142odzimierz Buczko","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I146122375","display_name":"Medical University of Bia\u0142ystok","ror":"https://ror.org/00y4ya841","country_code":"PL","type":"education","lineage":["https://openalex.org/I146122375"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"W\u0142odzimierz Buczko","raw_affiliation_strings":["Department of Pharmacodynamics, Medical University of Bia\u0142ystok, Mickiewicza 2C, PL 15-089 Bia\u0142ystok, Poland. pharmdyn@amb.edu.pl"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacodynamics, Medical University of Bia\u0142ystok, Mickiewicza 2C, PL 15-089 Bia\u0142ystok, Poland. pharmdyn@amb.edu.pl","institution_ids":["https://openalex.org/I146122375"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018640532","display_name":"Justyna Magdalena Hermanowicz","orcid":"https://orcid.org/0000-0002-3985-4244","observed_orcids":["https://orcid.org/0000-0002-3985-4244"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Justyna M Hermanowicz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.2973,"has_fulltext":false,"cited_by_count":42,"citation_normalized_percentile":{"value":0.92166327,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"60","issue":"5","first_page":"623","last_page":"31"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aliskiren","display_name":"aliskiren","score":1.0},{"id":"https://openalex.org/keywords/renin-inhibitors","display_name":"renin inhibitors","score":0.8500000238418579},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.968999981880188},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9980000257492065},{"id":"https://openalex.org/keywords/plasma-renin-activity","display_name":"plasma renin activity","score":0.9259999990463257},{"id":"https://openalex.org/keywords/angiotensin-i","display_name":"angiotensin I","score":0.9670000076293945},{"id":"https://openalex.org/keywords/angiotensin-ii","display_name":"angiotensin II","score":0.9409999847412109},{"id":"https://openalex.org/keywords/renin-angiotensin-system","display_name":"renin-angiotensin system","score":0.8650000095367432},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.6729999780654907},{"id":"https://openalex.org/keywords/antihypertensive-drugs","display_name":"antihypertensive drugs","score":0.859000027179718},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.7730000019073486},{"id":"https://openalex.org/keywords/plasma-protein-binding","display_name":"plasma protein binding","score":0.796999990940094},{"id":"https://openalex.org/keywords/cyp3a4-metabolism","display_name":"CYP3A4 metabolism","score":0.9710000157356262},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.875},{"id":"https://openalex.org/keywords/drug-tolerance","display_name":"drug tolerance","score":0.4620000123977661}],"concepts":[{"id":"https://openalex.org/C2779838083","wikidata":"https://www.wikidata.org/wiki/Q414904","display_name":"Aliskiren","level":4,"score":0.9949942827224731},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.740420937538147},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6767629981040955},{"id":"https://openalex.org/C2777425892","wikidata":"https://www.wikidata.org/wiki/Q409255","display_name":"Renin inhibitor","level":4,"score":0.6706253290176392},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.6492819786071777},{"id":"https://openalex.org/C198710026","wikidata":"https://www.wikidata.org/wiki/Q898218","display_name":"Renin\u2013angiotensin system","level":3,"score":0.6437939405441284},{"id":"https://openalex.org/C138976137","wikidata":"https://www.wikidata.org/wiki/Q7201790","display_name":"Plasma renin activity","level":4,"score":0.584305465221405},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.5394831895828247},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5187187790870667},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.47224587202072144},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34065482020378113},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.33690115809440613},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.1538349688053131}],"mesh":[{"descriptor_ui":"D000092502","descriptor_name":"Renin Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000577","descriptor_name":"Amides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000577","descriptor_name":"Amides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000577","descriptor_name":"Amides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000577","descriptor_name":"Amides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005650","descriptor_name":"Fumarates","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005650","descriptor_name":"Fumarates","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D005650","descriptor_name":"Fumarates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005650","descriptor_name":"Fumarates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D012083","descriptor_name":"Renin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D012084","descriptor_name":"Renin-Angiotensin System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":3,"locations":[{"id":"pmid:19066408","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19066408","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological reports : PR","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.418.8031","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.418.8031","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://rabbit.if-pan.krakow.pl/pjp/pdf/2008/5_623.pdf","raw_type":"text"},{"id":"mag:71275700","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19066408","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":52,"referenced_works":["https://openalex.org/W1496645496","https://openalex.org/W1881361989","https://openalex.org/W1909110915","https://openalex.org/W1967754040","https://openalex.org/W1975256321","https://openalex.org/W1978958912","https://openalex.org/W1993114157","https://openalex.org/W1997388963","https://openalex.org/W1999748957","https://openalex.org/W2000314850","https://openalex.org/W2004857031","https://openalex.org/W2008494063","https://openalex.org/W2009311646","https://openalex.org/W2012577336","https://openalex.org/W2015569360","https://openalex.org/W2016485702","https://openalex.org/W2018024340","https://openalex.org/W2026232111","https://openalex.org/W2027870509","https://openalex.org/W2044049836","https://openalex.org/W2053007571","https://openalex.org/W2061170043","https://openalex.org/W2077362814","https://openalex.org/W2084140014","https://openalex.org/W2085376059","https://openalex.org/W2085927807","https://openalex.org/W2091237886","https://openalex.org/W2093449144","https://openalex.org/W2095289884","https://openalex.org/W2096211964","https://openalex.org/W2096622096","https://openalex.org/W2098312479","https://openalex.org/W2102953371","https://openalex.org/W2107375710","https://openalex.org/W2107914594","https://openalex.org/W2121754021","https://openalex.org/W2127790911","https://openalex.org/W2131454364","https://openalex.org/W2139637918","https://openalex.org/W2145461177","https://openalex.org/W2152299939","https://openalex.org/W2159934415","https://openalex.org/W2161755293","https://openalex.org/W2164834486","https://openalex.org/W2166710642","https://openalex.org/W2166819422","https://openalex.org/W2171818587","https://openalex.org/W2318419775","https://openalex.org/W2332388216","https://openalex.org/W2342909692","https://openalex.org/W2408207942","https://openalex.org/W2415985715"],"related_works":["https://openalex.org/W7099453422","https://openalex.org/W2136465695","https://openalex.org/W2034783882","https://openalex.org/W4251639154","https://openalex.org/W2031278591","https://openalex.org/W2144815880","https://openalex.org/W2417777944","https://openalex.org/W2088947312","https://openalex.org/W2092410606","https://openalex.org/W2138386879"],"abstract_inverted_index":{"Intensive":[0],"efforts":[1],"have":[2],"been":[3],"spent":[4],"to":[5,34,41,91,141,167,172],"discover":[6],"therapeutic,":[7],"non-peptide":[8],"and":[9,59,70,73,94,120,127,149,163,177,186,189],"orally":[10],"effective":[11],"hypertensive":[12],"drugs.":[13],"One":[14],"drug":[15,155],"that":[16,28,147],"emerged":[17],"from":[18],"this":[19],"effort":[20],"is":[21,81,104,124],"aliskiren,":[22],"a":[23,65,142,158,169],"direct":[24],"human":[25,53],"renin":[26,48],"inhibitor":[27],"blocks":[29],"the":[30,95,152,165,182],"conversion":[31],"of":[32,56,62,79,145,161,184],"angiotensinogen":[33],"angiotensin":[35,173,178],"I":[36,72],"(Ang":[37],"I).":[38],"In":[39,51],"contrast":[40],"other":[42,136,187],"antihypertensive":[43,137],"agents,":[44],"aliskiren":[45,63,80],"decreases":[46],"plasma":[47,85,98],"activity":[49],"(PRA).":[50],"healthy":[52],"subjects,":[54],"doses":[55],"between":[57],"40":[58],"640":[60],"mg":[61],"exert":[64],"dose-dependent":[66],"reduction":[67],"in":[68,133,181],"PRA":[69],"Ang":[71,74],"II":[75],"levels.":[76],"The":[77,110],"bioavailability":[78],"low":[82],"(2%),":[83],"peak":[84],"concentrations":[86],"are":[87],"reached":[88],"within":[89],"one":[90],"three":[92],"hours":[93],"binding":[96],"with":[97,135],"proteins":[99],"achieves":[100],"approximately":[101],"47-51%.":[102],"Aliskiren":[103,123,139],"slightly":[105],"metabolized":[106],"(20%)":[107],"by":[108],"CYP3A4.":[109],"most":[111],"common":[112],"adverse":[113],"events":[114],"include":[115],"diarrhea,":[116],"headache,":[117],"back":[118],"pain":[119],"gastrointestinal":[121],"disorders.":[122,191],"well":[125],"tolerated,":[126],"may":[128],"be":[129],"used":[130],"alone":[131],"or":[132],"combination":[134],"agents.":[138],"belongs":[140],"new":[143],"class":[144],"agents":[146],"effectively":[148],"specifically":[150],"inhibit":[151],"RAS.":[153],"This":[154],"functions":[156],"through":[157],"novel":[159],"mechanism":[160],"action":[162],"has":[164],"potential":[166],"become":[168],"true":[170],"alternative":[171],"converting":[174],"enzyme":[175],"inhibitors":[176],"receptor":[179],"blockers":[180],"therapy":[183],"hypertension":[185],"cardiovascular":[188],"renal":[190]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":6},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}